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S100 proteins comprise a family of Ca2+ binding proteins of at least 21 members. They are distinctly expressed in a variety of cell types and
tissues and are thought to play unique roles, although they share a high degree of sequence homology and expression overlap. S100A1 is
prominently expressed in the heart, where it takes part in Ca2+-cycling. Its role in the central nervous system (CNS) is largely unknown. We have
generated S100A1-deficient mice by gene trap mutagenesis to study the involvement of S100A1 in the cytoarchitecture of the brain, in learning
and memory, and in avoidance-approach behavior. S100A1 knock out (KO) mice develop well and their brains present with normal morphology.
In wild type (Wt) mice, S100A1 protein was found in the hippocampus, cerebral cortex and amygdala, and partially co-localized with the astrocyte
marker glial fibrillary acidic protein (GFAP) in the stratum radiatum of the hippocampus. Astrocytes and neurons of S100A1KO mice did not
differ from those of Wt mice regarding shape, distribution and density. In the water maze, S100A1KO mice performed equally well as Wt,
implying that S100A1 is not involved in spatial learning and memory. In avoidance-approach tests, predominantly male S100A1KO mice showed
reduced anxiety-like responses and enhanced explorative activities. We conclude that S100A1 plays a role in modulating innate fear and
exploration of novel stimuli.
© 2006 Elsevier B.V. All rights reserved.Keywords: S100; Mouse; CNS; Anxiety; Exploration; Immunohistochemistry1. Introduction
S100 proteins form a family of Ca2+-binding proteins,
comprising at least 21 members (reviewed in [1–4]). They
occur as dimers or multiples of dimers and interact with other
proteins in a Ca2+-dependent and -independent manner. S100Abbreviations: CNS, central nervous system; HPLC, high performance
liquid chromatography; KO, knock out; PGK, phosphoglycerate kinase-1; PCR,
polymerase chain reaction; RT, reverse transcription; Wt, wild type
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doi:10.1016/j.bbamcr.2006.08.048proteins are mostly cytosolic and can have intracellular as well
as extracellular functions (reviewed in [5–9]).
S100 family members are expressed in many tissues, and
each tissue expresses a unique constellation of them. Using
quantitative northern blotting, S100A1 was shown to be most
prominently expressed in the heart, and with decreasing levels
in the kidney, liver, skin, brain, lung, stomach, testis, muscle,
small intestine, thymus and spleen [10]. S100B was found to
be expressed in the brain only at about the same levels as
S100A1 [10]. On the protein level, S100A1, S100A2,
S100A4, S100A5, S100A6, S100A10, S100A11, S100A13,
S100A16 and S100B were all detected in brain tissue [10–12].
In the mouse, S100B primarily occurs in astrocytes, but also
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the granule layer of the cerebellar cortex and shown to
partially co-localize with the synaptic vesicle phosphoprotein
synapsin I in nerve endings of the cerebral and cerebellar
cortices [14]. S100A1 was demonstrated to inhibit the F-actin
bundling activity of synapsin I, suggesting that S100A1 may
modulate the cytoskeleton for neurotransmitter release in
neurons [14]. S100A1 protein is up-regulated in response to
nerve growth factor (NGF)-induced differentiation in the
neuroendocrine PC12 cell line [15]. Increased S100A1 protein
levels have also been documented during cell differentiation
of the glial C6 cell line [16]. In addition, S100A1-deficient
PC12 cells exhibit reduced proliferation, elevated levels of α-
tubulin and an increase in the number and length of neurites
upon addition of NGF [17]. Ablation of S100A1 in PC12
cells is also associated with reduced basal [Ca2+]i levels,
enhanced ionomycin-induced Ca2+ release, elevated levels of
intracellular amyloid precursor protein (APP) and an
increased resistance to amyloid β-induced cell death [10].
Although secretion of S100A1 has not yet been observed, this
protein was reported to exert trophic effects in vitro on
neurons expressing the receptor for advanced glycation end
products (RAGE) [18]. In vivo administration of S100A1
antibodies to chicks immediately after training for a passive
avoidance task was reported to result in amnesia [19].
S100B plays a plethora of intracellular and extracellular
roles among neurons and astrocytes in vitro [20–26] (and
reviewed in [9,27]). However, evidence that these are
essential in vivo functions is scarce. S100B knock out
mice exhibit no overt abnormalities and no detectable
alterations in the cytoarchitecture of the brain. Considering
that S100B was reported to be one of the most potent trophic
factors for serotonergic neurons (reviewed in [28]), it is
surprising that these neurons developed normally in the brain
of S100B-deficient mice [29]. However, S100B knock out
mice showed a higher incidence of severe seizures in
response to amygdala kindling (a measure of epileptic
activity) [30], and enhanced long-term potentiation in the
hippocampal CA1 region paralleled by an improved spatial
memory in the Morris water maze and a sensitized fear
memory in a contextual fear conditioning paradigm [31]. In
addition, neonatal cerebellar glial cells from S100B null mice
showed increased Ca2+-transients upon KCl and caffeine
treatment [32], and astrocytes from S100B knock out mice
were found to be in an activated state and insensitive to
serotonin signaling [33].
The in vivo role of S100A1 in the nervous system has not
yet been investigated. So far, a mouse model of S100A1-
deficiency was used to analyze the role of S100A1 in cardiac
function and revealed the importance of S100A1 in cardiac
contractility and relaxation in response to β-adrenergic
stimulation and hemodynamic stress [34]. We have generated
S100A1-deficient mice by gene trap mutagenesis and studied
the effects of S100A1 loss-of-function in the CNS. Here we
demonstrate that absence of S100A1 results in reduced
anxiety-like responses and enhanced exploratory behavior in
male mice.2. Materials and methods
2.1. Generation of S100A1-deficient mice and identification of the
mutated locus
Searching the Omni Bank database (http://www.lexgen.com) for mouse ES
cell clones (129S5/SvEvBrd) with retroviral insertions in the S100A1 gene [35],
we found clone OST28275 in which the integration site for the retroviral gene
trap was located in the second intron of the S100A1 gene, disrupting the coding
region midway. This clone was injected into host blastocysts (C57BL/6 albino)
for implantation in pseudopregnant female mice. The resulting chimeras (F0)
were crossed with hybrid C57BL/6-129/SvEv Wt mice for two generations, and
heterozygous F2 mice were supplied to us (Lexicon Genetics, The Woodlands,
Texas, USA). For genotyping and identification of the gene disruption, we
performed Southern blotting, genomic PCR and sequencing of the mutated
locus. Southern analysis was realized according to the protocol provided by
Lexicon Genetics using EcoI digested tail genomic DNA, and 32P-labeled
probes from full-length S100A1 (AA109939) and neomycin phosphotransfer-
ase cDNAs. For PCR analysis, genomic DNA was extracted from mouse tails
and subjected to PCR (REDExtract-N-Amp Tissue PCR Kit, Sigma, Buchs,
Switzerland) using primer pairs specific for the Wt (S100A1 exon 2 forward,
ex2-F: 5′-AAC TGA ACT TTC TGG CTT CCT-3′; S100A1 exon 3 reverse,
ex3-R: 5′-CTT GTC CAC AGC ATC TGC ATC-3′) and the mutated (ex2-F:
dito; 5′LTR reverse, 5′LTR-R: 5′-ATA AAC CCT CTT GCA GTT GCATC-3′)
S100A1 loci. Amplification was started with a denaturation step at 95 °C for
3 min, followed by 36 cycles at 95 °C, 58 °C and 72 °C for 30 s at each
temperature , and a single elongation step at 72 °C for 7 min. For identifying the
site of the retroviral insertion, PCR products from amplifications using ex2-F
and 5′LTR-R primers were cloned (TOPO TA cloning, Invitrogen, Basel,
Switzerland) and sequenced (BigDye Terminator v1.1 Cycle Sequencing Kit
and GeneAmp PCR system 9700, Perkin Elmer, Applied Biosystems, Rotkreuz,
Switzerland).
Mice were maintained in an approved animal facility (Biologisches
Zentrallabor, University of Zürich), and had access to food and water ad
libitum. Animal handling and experimentation were performed according to the
regulations of the Biologisches Zentrallabor, University of Zürich, and the
Veterinary Department of the canton of Zürich. The mutated S100A1 allele (F2)
was transmitted through two crosses between heterozygous mice (F4) to largely
maintain the mixed C57BL/6-129/SvEv background for the behavioral studies,
blood plasma parameter determination and Southern/northern analyses. For all
other studies, the mutated S100A1 allele was backcrossed to C57BL/6J inbred
mice for at least 10 generations, and homozygous mutant and Wt mice were
generated by intercrossing non-sibling, homozygous mutant and Wt offspring
mice.
2.2. Expression analysis of gene trapped S100A1 by northern blotting
and RT-PCR
RNAwas isolated using RNeasy Kits from Qiagen (Basel, Switzerland). For
northern hybridization, 10 μg of total RNA from each type of tissue and
genotype was resolved on an agarose gel and blotted onto a nylon membrane
according to a standard protocol (Current Protocols in Molecular Biology, http://
www3.interscience.wiley.com/cgi-bin/browsebyproduct?type=5). Full length
cDNA sequences of mouse S100A1 (AA109939) and human β-actin (Clontech
#636828, Beckton & Dickinson, Allschwil, Switzerland) were 32P-labeled and
used as probes. For RT, 1 μg of DNase-digested (DNA-free™, Ambion Europe
Ltd., Huntingdon, UK) total brain RNA was reverse transcribed (TaqMan®
Reverse Transcription Reagents, Applied Biosystems) in 50 μl reaction volume
according to the manufacturers' protocols using oligo-dT(15) or gene specific
primers (5′-AGG TCT TTC AGT TCT TTC TTG C-3′). For the PCR, 2 μl RT
reaction volume was mixed with gene specific primers (for S100A1: ex1-F: 5′-
GGA GGT CGG TAG GGA AAG-3′, ex2-R: 5′-CCC GAA TGG GCA TGG
AAC AC-3′, ex3-F: 5′-TGT GGA CAA GGT AAT GAA GG-3′, ex3-R2: 5′-
GGG ACA TAG GGA GGT ACA GG-3′, ex3-R3: 5′-GAT CTG GAC TGC
CAC TCT TG-3′; for β-galactosidase: F: 5′-GCG CGA ATT GAATTATGG-
3′, R: 5′-CTC GTC CTG CAG TTC ATT C-3′; for vinculin: F: 5′-AAT GGG
AAA CCA ACT TTC AC-3′, R: 5′-AGG AGC TAA CAG GCT GAC AC-3′)
and REDTaq® ReadyMix™ PCR Reaction Mix (Sigma) and amplified for
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denaturation step at 94°C for 3 min and a terminal elongation step at 72 °C for
7 min.
2.3. Plasma parameter and brain neurotransmitter metabolite
determination
Blood from 3 to 4 months old S100A1KO andWt male and female mice was
collected in Li-heparin tubes and centrifuged for 10 min at 1000×g to separate
plasma from cells. Plasma sodium, potassium, chloride, calcium, magnesium,
glucose, lactate and creatinine concentrations, as well as lactate dehydrogenase,
creatine kinase (CK), and creatine kinase-MB (CK-MB) enzyme activities were
measured on a UniCelDxC600, Beckman Coulter, Nyon, Switzerland. Cysteine
was determined by HPLC on a Biochrom 20 Plus analyzer, Amersham
Pharmacia Biotech, and homocysteine on a System Gold analyzer, Beckman
Coulter, Nyon, Switzerland. All parameters were determined according to the
guidelines for routine clinical analyses.
Six months old S100A1KO and Wt male and female mice were killed by
CO2, decapitated, and brains were removed, weighed, immediately frozen in
liquid N2 and stored at −80 °C until use. Brains were pulverized in a liquid N2-
cooled mortar using a pestle and homogenized in 4 mL ice cold extraction buffer
(6.8 g/L NaH2PO4, 1.082 g/L octan sulfonic acid, 0.0025% EDTA, 0.238%
H3PO4, 23% methanol) by vortexing and ultrasonication (4×30 s on ice). The
opaque brain protein suspension was centrifuged at 4 °C, 600×g for 10 min, the
supernatant removed for an additional centrifugation step at 4 °C, 10,000×g for
10 min, and protein concentrations were determined for normalization (2-D
Quant Kit, GE Healthcare Europe). Avolume of 200 μL brain extract was mixed
with 20 μL trichloric acid for precipitation, chilled on ice for 5 min and
centrifuged at 4 °C, 1000×g for 1 min. The supernatant was mixed 1:1 with
extraction buffer, centrifuged through a Millipore Ultrafree 10,000 Filter Unit at
4 °C, 6000×g for 5 min, and 80 μL of the filtrate were analyzed on a reverse-
phase HPLC system (YMC Pack Pro, C18, 5 μm, 250×4.6 mm, flow rate
1.2 mL/min, mobile phase identical with extraction buffer) with quantitative
electrochemical detection. Concentrations were estimated by using external
calibration curves that were generated concomitantly.
2.4. Immunostainings
Mouse brains were dissected and homogenized as described above using a
different homogenization buffer (40 mMTris–HCl [Sigma], pH 7.4, 4%CHAPS
[Sigma], Protease Inhibitor Cocktail [Roche, Rotkreuz, Switzerland]). Twenty
micrograms protein per slot were loaded on a 8–16% Tris–glycine mini gel
(Invitrogen), and gel electrophoresis and immunoblotting were performed
according to a standard protocol (Current Protocols in Proteins Science, http://
www3.interscience.wiley.com/cgi-bin/browsebyproduct?type=5). Blots were
blocked for 20–60 min in Tris buffered saline (TBS) containing 0.05% Tween-
20, 10% horse serum, 5% BSA and optionally 5% fat-free milk powder.
Antibodies were incubated in blocking solution overnight at 4 °C on a shaker.
They were diluted and purchased as follows: rabbit anti-human S100A1 (1:500),
DakoCytomation #A5109, Glostrup, Denmark; mouse anti-E. coli β-galactosi-
dase (1:1000), Promega #Z378, Catalys AG, Wallisellen, Switzerland; mouse
anti-Src (1:000), Santa Cruz #sc-8056, Labforce, Nunningen, Switzerland;
mouse anti-Protein Gene Product 9.5 (PGP9.5; 1:40,000), Ultraclone Ltd.
#13C4, Wellow, UK; horseradish peroxidase-linked sheep anti-mouse IgG
(1:10,000) and horseradish peroxidase-linked donkey anti-rabbit IgG (1:10,000),
both from GE Healthcare UK Ltd., Little Chalfont, UK. After six wash steps of
10 min each, blots were blocked again for 20–60 min and incubated with
secondary antibodies for 2 h. After six wash steps of 10 min each, blots were
submerged in substrate solution (SuperSignal West Pico Chemiluminescent
Substrate, Pierce, Socochim, Lausanne, Switzerland) according to the manufac-
turer's protocol and exposed to Kodak BioMax Light Film (Sigma) for
chemiluminescence detection.
For double immunofluorescence staining of brain sections, three months old,
female S100A1KO and Wt mice, weighing 20 to 25 g, were deeply anesthetized
with 3.5% chloral hydrate (Riedel-de Haën, Germany, 1 ml/100 g) and perfused
transcardially with 0.9% saline, followed by about 300 ml of cold 4%
paraformaldehyde in phosphate buffered saline (PBS), pH 7.4. Brains weredi2ssected and postfixed with the same fixative overnight before they were
immersed in 30% sucrose for at least 24 hours. After cryoprotection with OCT
compound (Tissue-Tek, Sakura, Japan), 40-μm thick serial longitudinal brain
sections were cut from frozen blocks with a cryostat (Shandon, USA). Free-
floating sections were blocked for one hour on a shaker at room temperature in
PBS containing 10% horse serum and 1% Triton, and subsequently incubated
with combinations of two primary antibodies, which were raised in different
species. Antibodies were diluted in blocking solution as follows: rabbit anti-
human S100A1 (Dako) 1:50, rabbit anti-human S100B (Dako) 1:25, mouse anti-
GFAP (Chemicon) 1:200 and mouse anti-Neuronal Nuclei Marker (NeuN;
Chemicon) 1:250. After an overnight incubation with the primary antibodies at
4 °C, the sections were washed with PBS three times each for five minutes
before they were incubated with Cy3-conjugated donkey anti-mouse (1:300
dilution) and Cy2-conjugated donkey anti-rabbit antibody (1:100 dilution) in
blocking solution for one hour at room temperature for visualization of
immunoreactive signals (both secondary antibodies were purchased from
Jackson ImmunoResearch Laboratory). The floating sections were washed three
times, each for five minutes, mounted on glass slides and examined under a
confocal laser scanning microscope (Bio-Rad MRC 1024). Digital images were
captured and merged using Photoshop (Adobe Photoshop 8.0), CorelDRAW
(Corel Corporation 12.0) and Confocal Assistant (version 4.02, Bio-Rad).
2.5. Behavioral studies
2.5.1. General procedures and animals for behavioral analysis
All behavioral procedures were approved by the Swiss animal welfare
authorities. The mice were transferred to single cages before the begin of the
experimental period and tested during the dark phase of the cycle (lights on
between 8 p.m. and 8. a.m.) [36]. Standard mouse chow, water and nesting
material were available ad libitum. The home cage rack was brought to the test
room at least 30 min before each experiment. Two cohorts (cohort 1: 16
S100A1KO, 16 Wt, average age 2.6 months at begin of testing, range 2.6–2.9;
cohort 2: 15 S100A1KO, 16 Wt, 6.0 months, range 5.7–6.5) with balanced
numbers of female and male mice performed behavioral tests in the following
order: water-maze, open field, light-dark box (LD-box), O-maze, emergence/
object exploration test. All experiments were video-tracked using a Noldus
EthoVision 1.96 system (Noldus Information Technology, Wageningen NL,
www.noldus.com) and raw data were transferred to the program Wintrack [37]
(www.dpwolfer.ch/wintrack) for analysis.
2.5.2. Behavioral procedures
Place navigation in the water-maze was tested as described in detail
previously [38]. In brief, a white, circular pool (150 cm diameter) contained
milky water (24–26 °C). Acquisition training consisted of 18 trials (6 per day,
inter-trial interval 30–60 min) during which the submerged platform
(14×14 cm) was left in the same position. Trials lasted a maximum of 120 s.
To monitor reversal learning, the platform was moved to the opposite position
for 2 additional days of training (6 trials per day). The first 60 s of the first
reversal trial served as probe trial to test for spatial retention. Floating episodes
were excluded before calculating swim speed.
Anxiety-related responses and exploratory activity were tested as described
in detail previously [39]. In brief, the open field was a dimly lit circular arena
(150 cm diameter) in which the mice were observed for 10 min each on two
consecutive days. The arena was divided into a wall zone (18% of surface, 7 cm
wide), a center zone (50%), and a transition zone. For the LD-box (bright
20×30×20, dark 20×10×30 cm) test [40], the mice were placed into the bright
compartment and observed for 5min. The bright chamberwas divided into a door
zone (32%), a zone along the opposite wall (27%), and a center zone in between.
For the O-maze (diameter 46 cm, runway width 5.5 cm) test [41], mice were
released into one of the two closed 90° sectors and observed for 10 min. At the
transitions between closed (total 28% of surface) and open (total 39%) sectors an
intermediate zone was defined from which the mice could perform protected
head dips without leaving the closed sector with all four paws. Twenty-four hours
prior to the emergence test, which was designed after [42], a home box
(12×8×4 cm) was placed in each mouse's home cage. The animals were
transferred to a square test arena (50×50 cm) together with the box (placed at
5 cm from one of the corners) and observed for 30 min. The arena was divided
into a home zone around the box (16% of surface including nearest corner), a
Fig. 1. Disruption of S100A1. (A) Representation of the S100A1 gene locus and
the retroviral gene trap insertion into the second intron of S100A1. S100A1 is a
three-exon gene intersected by two introns (sizes are given in bp). The position
of translation initiation is indicated by right-angled arrows. The gene trap vector
has an approximate size of 6.2 kb, and contains 5′- and 3′-long terminal repeats
(5′ and 3′LTRs), a β-galactosidase/neomycin phosphotransferase fusion gene
(β-geo), which is flanked by a splice acceptor (SA), an internal ribosomal entry
site (IRES) and a polyadenylation sequence (pA), and a puromycin N-acetyl-
transferase gene (puro), which is flanked by the phosphoglycerate kinase-1
promoter (PGK) promoter and a splice donor sequence (SD). Arrows indicate
PCR primer binding sites for genotyping and expression analyses. The retroviral
insertion would produce two fusion transcripts, one containing exons 1 and 2 of
the trapped S100A1 and the β-geo (marker/selector), and the other containing
the sequences of puro and exon 3 of the trapped S100A1 (Omnibank sequence-
tag [OST]). (B) PCR genotyping of S100A1-disrupted mice. Two sets of PCRs
were performed from each mouse tail genomic DNA using primer combinations
ex2-F/ex3-R1 and ex2-F/5′LTR-R. In Wt (+/+) mice, only a PCR product
(686 bp) from primer pair ex2-F/ex3-R1 can be produced, whereas in
homozygous mutant mice (−/−) a single PCR product (320 bp) from primer
pair ex2-F/5′LTR-R can be observed. Accordingly, in heterozygous mice (+/−)
both, the 686- and 320-bp PCR amplicons are generated from primer pairs ex2-
F/ex3-R1 and ex2-F/5′LTR-R, respectively. (C) Southern blot analysis of
EcoRI-digested genomic DNA extracted from tail tips of (+/+), (+/−) and (−/−)
mice using a full-length S100A1 cDNA probe. A single band of approximately
5.2 kb (1) corresponding to the expected size of the EcoI fragment in the
S100A1 locus is visible in (+/+) and (+/−). Two bands of approximately 5.4 kb
(2) and 3.0 kb (3) that were produced due to the retroviral insertion are visible in
(−/−) and (+/−), but not in (+/+) mice. Heterozygotes (+/−) show about half the
intensity of band 1 when compared to (+/+), and about half the intensities of the
mutant bands 2, 3 when compared to (−/−), which corresponds to the
distribution of the Wt and the mutant allele.
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began on the following daywith themice habituating to the same arena for further
30min, but without home box. A 50-ml Falcon tubewas placed vertically into the
center of the arena and observation continued for another 30 min. The arena was
divided into an object zone from which the animal could at least touch the object
(18 cm diameter, 10% of surface), a wall zone (36% of surface, 5 cm wide), and a
transition zone in between. All zone definitions are based on average occupancy
by a large population ofmice. Recorded tracks of all experimentswere segmented
into three motion states according to criteria modified from [43]: bouts of
progressive locomotion, episodes of small lingering movements, which correlate
with various exploratory behaviors such as phases of rearing and resting
(including grooming). Vertical activity was estimated from changes of the
apparent subject area in absence of locomotion. In order to facilitate comparisons
across tests with different duration, activity measures are shown per minute
observation time.
2.5.3. Statistics
Behavioral data were analyzed using a 3-way factorial ANOVA model with
genotype (KO, Wt), gender and cohort as between subject factors. Floating time
in the water-maze and latency measures in the exploration tests were log
transformed. The cohort factor was added in order to reduce unexplained
variance and to check for cohort dependence of genotype effects. It is not
reported in the figures and tables because none of the genotype effects was
cohort dependent, which concomitantly indicates age-independence of our
observations. By contrast, gender×genotype interactions were significant for
several variables. Therefore, this interaction factor is reported for all tests, along
with partial ANOVA results for female and male mice. As needed to analyze
time and zone dependence of effects, the ANOVA models were expanded by
inclusion of within subject factors trial (block) or zone as indicated in the figure
legends. Effects were considered significant if p<0.05, non significant trends
are reported up to p<0.10. Effect sizes were estimated as partial omega squared,
the proportion of variance accounted for by genotype if only the factor of interest
were in the design, range 0 to 1.0 [44]. One sample t-tests were used to compare
group means with hypothesized means such as chance values. Statview 5.0.1
(www.statview.com, no longer sold) or MS Excel 2003 were used for all
statistical computations.
3. Results
3.1. Disruption of the S100A1 gene
Gene trap mutagenesis generates loss-of-function mutations
by random retroviral insertions, and uses the transcriptional
regulation apparatus of the recipient gene to report the disruption
by a marker/selector gene (reviewed in [45]). The large-scale
introduction of gene trap vectors into mouse embryonic stem
(ES) cells and the subsequent selection of a specific clone
carrying the mutation of interest were followed by Lexicon
Genetics Inc. For the generation of the mouse line of choice,
they deposited the sequences of more than 270,000 ES cell gene
trap insertions into their OmniBank database (http://www.
lexicon-genetics.com/discovery/omnibank.htm). By searching
this database, we identified clone OST28275 harboring an
insertion in intron 2 of S100A1 and used it for the generation of
S100A1-deficient mice. The retroviral integration is expected to
disrupt the translation of S100A1 midway, producing two
chimeric proteins: one consisting of amino acids 1–47 of
S100A1 (encoded by exon 2) and the β-galactosidase/neomycin
phosphotransferase (β-geo) fusion gene, and the other consist-
ing of the puromycin N-acetyltransferase (puro) and amino
acids 48–94 of S100A1 (encoded by exon 3) (Fig. 1A). The
genotypes of the offspring generated from intercrosses between
heterozygous mice were determined by genomic PCR andSouthern hybridization analyses. For the PCR, a forward and
reverse primer specific for the S100A1 gene (ex2-F and ex3-R),
and an additional reverse primer for the inserted gene trap
vector (5′LTR-R) were designed to generate a Wt amplicon of
686 bp and a mutant amplicon of 320 bp. PCR on tail tip DNA
Fig. 2. Transcriptional and immunoblot analyses of gene trapped S100A1. (A)
Tissue-specific northern hybridization of Wt (+/+) and S100A1-disrupted mice
(−/−). A S100A1-reactive band of the expected size is visible in Wt but not
homozygous mutant tissues. Hybridization with human β-actin was used to
check for equal loading. (B) RT-PCR of the 5′ and 3′ gene trap components
using total brain RNA. The 5′ component requires transcription from the
S100A1 promoter, and includes exons 1 and 2 of S100A1 and β-geo, whereas
the 3′ component is driven by the PGK promoter, and includes puro and exon 3
of S100A1. S100A1 transcripts spanning exons 1–3 or 1–2 are amplified in (+/+)
at the expected sizes (491 and 190 bp, respectively), but not in (−/−). A β-
galactosidase (β-gal) transcript of the expected size (447 bp) is produced in (−/−)
but not in (+/+). Exon 3 of S100A1 is almost not detectable in the (−/−), but
readily visible in the (+/+). The amplification of vinculin was included in all RT-
PCRs as a positive control. L: DNA 100-bp ladder, the brightest band has a size
of 600 bp. (C) Immunoblotting showing the presence of S100A1 in the (+/+) and
its absence in the (−/−). In the opposite way, β-galactosidase can be detected in
the (−/−), but not in the (+/+). Src and PGP9.5 were used as loading controls.
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(−/−) mice resulted in DNA bands of the expected sizes, i.e. Wt
mice showed a single band of 686 bp, heterozygous mice two
bands of 686 and 320 bp, and homozygous mutant mice a single
band of 320 bp (Fig. 1B). Sequencing of the mutant PCR
amplicon determined the site of the gene trap insertion 199 bp
downstream of exon 2 (Fig. 1A). Southern hybridization using
EcoR1 digested tail DNA of Wt (+/+), heterozygous (+/−) and
homozygous mutant (−/−) mice and full-length S100A1 cDNA
as a probe revealed a single band of about 5.2 kb in theWt, which
was also visible in the heterozygous (Fig. 1C). In the mutant, two
bands of about 5.4 and 3 kb were detected, which also appeared
in the heterozygote and indicated retroviral insertion. The
intensities of the three bands in the heterozygote reflect allelic
distribution. An additional hybridization with a vector-specific
probe encoding neomycin phosphotransferase showed that
retroviral integration was a single event (data not shown).
3.2. Transcriptional characterization of the gene trap insertion
Gene trap insertions mutate genes by preventing the
production of the endogenous transcript. They force exons on
the 5′ side of the insertion to join with the splice acceptor of the
gene trap vector, and prevent splicing into the endogenous
exons on the 3′ side of the insertion. To verify that the
production of S100A1 transcripts is disrupted in homozygous
mutant mice (−/−), RNA was isolated from selected tissues,
known to normally express the transcript, and subjected to
northern hybridization using a probe complementary to full-
length S100A1. As expected, S100A1 was present in all tissues
derived fromWt (+/+) mice, with highest levels of expression in
the heart and kidney, medium levels in liver, lung and skeletal
muscle, and lowest levels in the brain (Fig. 2A). This is roughly
consistent with results obtained using quantitative northern
hybridization [10]. None of the RNA derived from homozygous
mutant mice (−/−) contained S100A1 transcripts, indicating that
this gene is knocked out (KO). Using a more sensitive method
to detect gene expression, we performed RT-PCR on total RNA
from whole brains. Again, S100A1 transcripts were only
detected in brain RNA from Wt (+/+), but not KO (−/−) mice
(Fig. 2B, S100A1 exon 1–3). In order to specifically analyze the
3′- and 5′-gene trap components, we used primers for the
amplification of exon 3 and exon 1/2 of S100A1, respectively.
The PGK promoter-driven S100A1 transcript on the 3′ side of
the insert (exon 3) was almost not detectable in brain RNA from
mutant mice, whereas the analogous transcript driven by the
S100A1 promoter was readily amplified from Wt brain RNA
(Fig. 2B, S100A1 exon 3). We do not think that the faint band
amplified from mutant brain RNA is due to DNA contamina-
tion, since omission of reverse transcriptase resulted in no
amplification product. Surprisingly, the S100A1 transcript on
the 5′ side of the insert (comprising exons 1 and 2) cannot be
found in KO (−/−) mice, although it is driven by the S100A1
promoter as in Wt (Fig. 2B, S100A1 exon 1–2). We can exclude
that this is due to different transcript lengths in Wt versus KO
RNA, since RTwith a reverse primer specific for S100A1 exon
2, and subsequent PCR using a more upstream primer pair onlyresulted in a band of the expected size in Wt but not in KO (data
not shown). The marker/selector fusion gene, β-geo, however,
which is also under the control of the S100A1 promoter in KO
mice, can be detected by RT-PCR and immunoblotting (Fig. 2B
β-gal, 2C). We therefore speculate that in the KO, the 5′-leader
of the primary RNA transcript is directly spliced into the β-geo
gene, thereby omitting exon 2 of S100A1 by exon skipping. The
absence of S100A1 in whole brain protein extracts of KO (−/−)
mice was also confirmed by immunoblotting (Fig. 2C).
3.3. Gross phenotypic characterization of S100A1KO mice
The progeny of heterozygous F1 mice was born at Men-
delian ratios, indicating that S100A1 is not essential for
embryogenesis and postnatal viability. S100A1KO mice were
fertile, had a normal life span and did not exhibit overt
phenotypic alterations. Independent of the genotype of the
parents, Wt and KO littermates developed equally well before
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during adulthood (mean body weights±sd at 6–8 months of
age; male Wt: 33.9±4 g, male KO: 32.6±3.1 g, female Wt:
25.5±0.6 g, female KO: 24.4±1.8 g). Similarly, brain weights
of KO were not altered (mean brain weights±sd at 6–8 months
of age, n≥8; male Wt: 537±26 mg, male KO: 533±24 mg,
female Wt: 550±31 g, female KO: 537±32 mg). Examination
of the external brain morphology and histological structures on
brain sections using a standard brain atlas did not reveal changes
in the KO. Blood plasma parameters, indicative of potential
pathophysiological alterations, did not significantly differ
between KO and Wt mice (Table 1).
The catecholaminergic neurotransmitters norepinephrine
(NE), serotonin (5-HT) and dopamine (DA) are known to
influence motor activity, sensorimotor gating, anxiety-related
behavior, learned fear, exploratory drive and cognitive function
in rodents. In order to investigate whether differences in
catecholaminergic neurotransmitters may underlie behavioral
alterations in KO mice, we measured levels of NE-, 5-HT and
DA metabolites in whole brain extracts from Wt and KO mice
by HPLC. Results revealed no significant differences between
Wt and KO (Table 1).
3.4. Localization of S100A1 and S100B in brains of S100A1KO
and Wt mice
In Wt mice, robust expression of S100A1 protein was
observed in various brain regions. To illustrate the expression
pattern, representative laser confocal micrographs were taken
from the hippocampus, amygdala and cerebral cortex (Fig. 3).
S100A1 immunoreactive (ir) cells were mostly medium-sized
with multiple cellular processes (Fig. 3A, C, D, E). They
scattered throughout the hippocampus, the amygdala and theTable 1
Blood plasma parameter and brain neurotransmitter metabolites determination in S1
Male
Wt
Plasma parameters #
Na+ (mmol/L) 151.9
K+ (mmol/L) 5.85
Cl− (mmol/L) 115.8
Ca2+ (mmol/L) 2.34
Mg2+ (mmol/L) 0.95
Glucose (mmol/L) 11.59
Creatinine (μmol/L) 46
Lactate (mmol/L) 13.48
Lactate dehydrogenase (IU/L) 262
Cysteine (μmol/L) 265
Homocysteine (μmol/L) 5.1
Creatine kinase (CK) (U/L) 493.4
CK-MB (U/L) 264
Neurotransmitter metabolites⁎
3-methoxy-4-hydroxyphenylglycol (MHPG) 9.2±4.5
5-hydroxy-3-indolacetic acid (5-HIAA) 57.6±26.1
3,4-dihydroxyphenylacetic acid (DOPAC) 16.6±5.9
4-hydroxy-3-methoxy-phanylacetic acid (HVA) 33.3±13.8
# Mean values of pools of n=6 per genotype and sex.
⁎ Mean values±sd in nmol/g protein; n=6 per genotype and sex.cerebral cortex with most of the immunoreactivity found in the
cell bodies, but also in the processes of cells in the stratum
radiatum of the hippocampus. Double staining for the astrocytic
marker glial fibrillary acidic protein (GFAP) revealed similarly
scattered GFAP-ir cells throughout the stratum radiatum of the
hippocampus (Fig. 3A′, B′) and cerebral cortex (not shown),
but not the amygdala (Fig. 3C′). GFAP-ir cells appeared
medium-sized with numerous slender and long processes.
Merging of the two stainings revealed that the cellular processes
and parts of the cytoplasm of S100A1- and GFAP-ir cells were
overlapping in the stratum radiatum (Fig. 3A″). There were also
some S100A1-positive cells in the striatum radiatum of the
hippocampus that were GFAP-negative. In KO mice, S100A1
expression was completely absent in all the brain regions
examined (Fig. 3B and data not shown), while GFAP expression
remained unchanged (Fig. 3B′ and data not shown). We also
used the neuronal marker NeuN to characterize S100A1-ir cells.
NeuN-ir cells (Fig. 3D′, E′) were much larger than GFAP-
positive cells (compare with Fig. 3A′, B′) and most of them
were multipolar with slightly immunoreactive long processes.
They were scattered in several brain regions including cerebral
cortex (3D′), amygdala (3E′) and stratum pyramidale of the
hippocampus (data not shown). Most of the S100A1-ir cells
were in close proximity to NeuN-ir cells (Fig. 3D″, E″). Similar
to double staining of S100A1 and GFAP in KO mice, S100A1
and NeuN double staining showed that S100A1 expression was
completely knocked out in all the brain regions examined, while
NeuN immunoreactivities remained the same as those observed
in Wt mice (data not shown).
S100B protein expression in Wt mice was found in cells
scattered in all the brain regions examined. S100B-ir cells
possessed medium-sized cell bodies and numerous long cellular
processes (Fig. 3F–J). S100B was found to co-localize with00A1KO and Wt mice
Female
KO Wt KO
151.7 149.1 149.2
5.84 4.77 5.00
113.7 114.8 116.3
2.41 2.27 2.27
0.92 0.87 0.93
9.63 10.65 10.86
47 48 46
13.72 5.95 8.43
190 228 237
281 232 260
5.4 7.0 7.4
378.0 275.1 403.3
233 217 241
11.2±8.4 14.1±4.3 11.9±1.8
70.0±31.6 97.0±32.3 84.2±23.3
17.7±8.5 19.8±6.5 16.8±3.7
46.8±21.8 48.9±13.9 40.8±11.3
Fig. 3. Confocal laser photomicrographs taken from the hippocampus, amygdala and cerebral cortex of S100A1KO andWtmice. Sections in the left panel show double
stainings of S100A1 (A to E) with either GFAP (A′ to C′) or NeuN (D′, E′), while in the right panel, sections are double stained for S100B (F to J) andGFAP (F′ to H′) or
NeuN (I′, J′). A″ to J″ are merged micrographs of A and A′ to J and J′, respectively. In Wt mice, S100A1 (green fluorescence in A, C, D, E) is expressed in cells of the
hippocampus (A), amygdala (C, E) and cerebral cortex (D). In S100A1KO mice, the expression of S100A1 is completely depleted (B), while GFAP expression (red
fluorescence in A′, B′) remains unchanged in the three brain regions examined (e.g. hippocampus B′). Co-expression of S100A1 and GFAP can be observed in the
stratum radiatum of the hippocampus, where the two staining patterns overlap (yellow fluorescence in A″). When the sections are double stained for S100A1 (D, E) and
NeuN (D′, E′), a close proximity of S100A1-ir cells (green fluorescence) and NeuN-ir cells (red fluorescence) is seen (D″, E″). In KO mice, S100A1 expression is
completely depleted in all the three brain regions examined, while NeuN expression is left unaffected (data not shown). S100B is expressed in Wt (F) and KO (G to J)
mice and co-localizes to cells immunoreactive to GFAP (F′ to H′) in the Wt (F″) and KO (G″, H″) in the hippocampus and cerebral cortex. In KO mice, the expression
patterns of S100B and GFAP are unchanged in the three brain regions examined (e.g. compare F, F′ and F″ with G, G′ and G″). Double staining of S100B (I, J) with
NeuN (I′, J′) shows close proximity of S100B-ir cells and NeuN-ir cells (I″, J″). Scale bar: 40 μm (C to C″ and J to J″) or 25 μm (for all other photomicrographs).
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cerebral cortex, both in the cell bodies and processes (Fig. 3F–
H, F′–H′, F″–H″). In KO mice, both the S100B and GFAP
expressions remained unchanged in the hippocampus (Fig. 3G,
G′, G″) and the cerebral cortex (Fig. 3H, H′, H″) when
compared with their Wt counterparts (Fig. 3F and data not
shown). Double staining for S100B and NeuN revealed no co-
localization. NeuN-ir cells were found to be relatively large with
slightly immunoreactive long processes, while S100B-ir cells
were small and interspersed between NeuN-ir cells. Theexpression patterns of S100B and NeuN in the cerebral cortex
(Fig. 3I, I′, I″), hippocampus (Fig. 3J, J′, J″) and amygdala (data
not shown) of Wt and KO mice were indistinguishable,
indicating that S100A1 deficiency did not affect the expression
of S100B and NeuN.
3.5. Behavioral studies
In order to assess spatial learning, memory and motor
function, S100A1KO and Wt mice were tested in a water-maze
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decreasing swim path length, they rapidly acquired the task
irrespective of genotype and gender (Fig. 4A, B). When the
platform was moved to the opposite quadrant, escape
performance decreased sharply, demonstrating that the mice
had adapted their swim strategy to the specific platform
location. KO and Wt mice adjusted with similar ease to theTable 2
Summary of p-values and effect sizes of S100A1KO and Wt mice in behavioral tes
Factorial ANOVA M+F genotype
Place navigation, training
Escape latency (s) ns
Swim path (m) ns
Cumulative search error (m s) ns
Wishaw's error (%) ns
Time near wall (%) ns
Swim speed (m/s) ns
Time floating (log s) ns
Place navigation, probe
Time in trained quadrant (% of 1st 60 s) ns
Time in train zone (% of 1st 60 s) ns
Annulus crossing index (x/m in 1st 60 s) ns
Average distance to target (m in 1st 60 s) ns
Radial error (m in 1st 60 s) ns
Open field
Distance moved (m/min) ns
Velocity while progressing (m/s) ns
Median absolute acceleration (m/s2) ns
Tortuosity index (°/m) ns
Wobbling index (°/m) ns
Jerkiness index (1/s3) ns
Time in center (%) ↑ p<0.0474 .05
Zone transitions (x/min) ↑ p<0.0458 .05
Distance moved, wall—center zone (m/min) ↓ p<0.0034 .12
LD-box
Distance moved (m/min visible) ns
Time in box (%) ns
Light–dark transitions (x/min) ns
Number of rearings (x/min visible) ns
Latency of first rearing (log s) ↓ ns
O-maze
Distance moved (m/min) ↑ p<0.0013 .14
Open sector entries (%) ↑ p<0.0007 .16
Latency to open sectors (log s) ↓ p<0.0188 .07
Head dips (x/min) ↑ p<0.0043 .11
Emergence test
Distance moved (m/min visible) ns
Area covered (%) ↑ p<0.0272 .07
Stereotypy index (%) ↓ p<0.0403 .06
Path predictability (%) ↓ p<0.0070 .11
Time in box (%) ↓ p<0.0894 .03
Object exploration
Distance moved (m/min) ↑ p<0.0178 .08
Corner time (%) ↓ p<0.0053 .11
Horizontal object exploration (m/min) ↑ p<0.0398 .06
Vertical object exploration (x/min) ↑ p<0.0409 .05
Object exploration episodes (x/min) ↑ p<0.0449 .05new platform position during reversal training. Male KO mice
even tended to have shorter swim paths, but the difference was
too small to reach statistical significance. Overall escape
performance of KO mice was also normal according to escape
latency, the cumulative search error, which calculates how much
time the animals loose swimming in places away from the
platform [46], and according to Whishaw's error, defined as %t (ns: not significant)
gender×genotype F genotype M genotype
ns ns ↓ ns
ns ns ↓ ns
ns ns ↓ ns
ns ns ns
ns ↑ ns ns
ns ns ns
ns ns ↓ ns
ns ns ns
ns ↓ ns ns
ns ↓ p<0.0412 .09 ns
ns ns ns
p<0.0006 ↑ p<0.0049 .19 ↓ p<0.0369 .10
ns ns ns
p<0.0912 ↓ ns ns
ns ns ns
ns ns ns
p<0.0561 ↑ ns ns
ns ns ↓ ns
ns ns ↑ p<0.0856 .07
ns ns ↑ p<0.0604 .09
ns ↓ p<0.0354 .10 ↓ p<0.0370 .12
ns ns ns
ns ns ns
ns ↓ ns ns
p<0.0526 ns ↑ p<0.0315 .13
p<0.0637 ns ↓ p<0.0162 .17
ns ↑ ns ↑ p<0.0032 .26
ns ↑ p<0.0850 .06 ↑ p<0.0015 .30
ns ns ↓ p<0.0165 .17
ns ↑ p<0.0570 .08 ↑ p<0.0440 .11
p<0.0102 ↓ ns ↑ p<0.0149 .19
ns ↑ ns ↑ p<0.0012 .33
ns ↓ ns ↓ p<0.0094 .21
ns ↓ p<0.0886 .06 ↓ p<0.0225 .16
ns ↓ ns ↓ ns
p<0.0183 ns ↑ p<0.0023 .27
p<0.0768 ns ↓ p<0.0038 .25
p<0.0407 ns ↑ p<0.0248 .15
p<0.0479 ns ↑ p<0.0259 .14
p<0.0666 ns ↑ p<0.0152 .17
Fig. 4. Training (A–B) and probe trial (C–D) performance of female (A, C) and
male (B, D) S100A1KO mice in the water-maze place navigation task. (A–B)
Swim path length, plotted as blocks of 2 trials (repeated ANOVA: genotype ns,
genotype×gender ns, time p<0.0001, genotype× time ns, genotype×time×
gender ns; females: genotype ns, time p<0.0001, genotype× time ns; males:
genotype ns, time p<0.0001, genotype×time ns). (C–D) Time spent in the
round target zone (12.5% of pool surface) compared to average of control zones
in adjacent quadrants (repeated ANOVA: place p<0.0001, place×genotype ns,
place×genotype×gender ns; females: place p<0.0001, genotype×place ns;
males: place p<0.0001, genotype×place ns).
Fig. 5. Behavior of female (A, C, E, G) and male (B, D, F, H) S100A1KO mice
in the open field (A–D), LD-box (E–F), and elevatedO-maze (G–H) tests. (A–B)
Total distancemoved in the open field, plotted as bins of 5 min on day 1 and day 2
(repeated ANOVA: genotype ns, genotype×gender ns, time p<0.0001,
genotype× time ns, genotype×time×gender p<0.0700; females: genotype ns,
genotype× time p<0.0381; males: genotype ns, genotype× time ns). (C–D) Zone
preferences in the open field (repeatedANOVA: zone p<0.0001, genotype×zone
p<0.0206, genotype×zone×gender ns, females: zone p<0.0001, genotype×-
zone ns; males: zone p<0.0001, genotype×zone p<0.0496). (E–F) Time spent
in the dark chamber of the LD-box (factorial ANOVA: genotype ns,
genotype×gender ns; one-sample t-test versus 50%: females p<0.0001, males
p<0.0001). (G–H) Sector preferences on the O-maze (repeated ANOVA: zone
p<0.0001, genotype×zone p<0.0595, genotype×zone×gender ns, females:
zone p<0.0001, genotype×zone ns; males: zone p<0.0001, genotype×zone
p<0.0996).
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We found no evidence for increased passivity (floating) or wall
hugging (thigmotaxis). Swim speeds of KO and Wt mice were
indistinguishable, indicating that motor performance was not
affected by the mutation. In addition to training performance,
we measured spatial retention in a probe trial at the beginning of
reversal 24 h after completion of acquisition training. KO and
Wt mice were indistinguishable with respect to % time spent in
the trained quadrant as well as average distance to target
(proximity) [46]. If the target zone was narrowed to a circle
comprising 12.5% of the pool surface in order to obtain a more
stringent measure of spatial selectivity, KO as well as Wt mice
still showed significant and similar preferences for the trained
goal zone compared to control zones in the adjacent quadrants
(Fig. 4C, D). However, the most stringent measure, the annulus
crossing index, which counts precise hits of the former goal
location, revealed a small deficit in female KO mice. No such
effect was present in male KO mice, but the contrast was too
small to result in a significant genotype×gender interaction.
The female KO group showed a marked tendency to respond to
the platform displacement with a short phase of wall hugging
and therefore had strongly increased scores on the radial error
measure. Because male KO mice showed a trend in the opposite
direction, the genotype×gender interaction was highly signif-
icant for this measure.
Fig. 6. Behavior of female (A, C, E) and male (B, D, F) S100A1KO mice in the
emergence (A–B), and object exploration (C–F) tests. (A–B) Total distance
moved in the emergence test (repeated ANOVA: genotype p<0.0335,
genotype×gender ns, time p<0.0001, genotype× time ns, genotype× time×
gender ns; females: genotype ns, time p<0.0001, genotype×time ns; males:
genotype p<0.0122, time p<0.0001, genotype× time p<0.0885; male
S100A1KO time p<0.0001, male Wt time p<0.0001). (C–D) Total distance
moved in the object exploration test (repeated ANOVA: genotype p<0.0342,
genotype×gender p<0.0226, time p<0.0001, genotype×time ns, genotype×
time×gender ns; females: genotype ns, time p<0.0001, genotype×time ns;
males: genotype p<0.0030, time p<0.0001, genotype× time ns. (E–F)
Horizontal exploratory activity directed toward the novel object (repeated
ANOVA: genotype p<0.0396, genotype×gender p<0.0407, time p<0.0001,
genotype×time p<0.0355, genotype× time×gender p<0.0293; females: geno-
type ns, time p<0.0001, genotype×time ns; males: genotype p<0.0248, time
p<0.0001, genotype× time p<0.0105).
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assessed in an open field, in the LD-box and on the elevated O-
maze (Table 2). In the open field, S100A1KO and Wt mice of
both genders were indistinguishable with respect to overall level
of locomotor activity. All groups showed habituation of
locomotor activity over time, with female KO mice tending to
be somewhat less active during the first day (Fig. 5A, B). All
experimental groups strongly preferred the wall zone at the
expense of the other zones, confirming that the large arena was
aversive (Fig. 5C, D). However, KO mice spent less time in the
wall zone, more time in the center and transitions zones
(p<0.0206), and entered the center and transitions zones
slightly more often than control mice. The reduced preference
of KO mice for the wall zone was more pronounced when we
considered the distribution of locomotor activity between wall
and center zone (p<0.0034). Even though separate analyses of
male and female mice suggested that male mice may contribute
somewhat more to the overall effect, there were no significant
genotype×gender interactions. Overall neurological and motor
function was normal in mutant mice as indicated by the
tortuosity, wobbling and jerkiness indices, although female KO
mice showed a slight increase in the wobbling index. In the LD-
box test, the mice spent significantly more time in the dark
compartment irrespective of genotype and gender (Fig. 5E, F).
There were also no differences with respect to number of light-
dark transitions and distance moved while in the lit compart-
ment. However, male KO mice began to rear sooner
(p<0.0162) and also performed more rearings than Wt mice
(p<0.0315). These effects were not present in female KO mice,
resulting in a borderline genotype×gender interaction. The
open sectors of the elevated O-maze were strongly aversive to
all experimental groups as evidenced by the distribution of
dwell time (Fig. 5G, H). However, avoidance of the open
sectors was clearly reduced in KO mice when considering %
open sector entries (p<0.0007) and latency to open sectors
(p<0.0188). Mutant mice also moved more on the maze
(p<0.0013) and performed more exploratory head dips
(p<0.0043). Even though no significant genotype×gender
interactions were present, separate analyses of female and male
mice again suggested that the overall effect was mainly
contributed by male mice.
Exploratory activity was further assessed in the emergence
and object exploration tests (Table 2), where animals have an
opportunity to retreat to a familiar zone. In the emergence
test, in which the mice explored a small arena from a familiar
home box, male but not female KO mice showed greater
locomotor activity than controls (Fig. 6A, B). The habituation
rate was normal and additional activity was not stereotypic.
Rather, path predictability was reduced (p<0.0070) and KO
mice visited a greater fraction of the arena surface in the
available time (p<0.0272). Mutants also spent slightly less
time inside the familiar home box (p<0.0894). This effect
was borderline, however, and too weak to resolve by gender.
During the object exploration test, an unknown object was
introduced into a familiar arena. Again, male KO mice were
generally more active (Fig. 6C, D) and more attracted by the
novel object than Wt siblings. Compared to controls, theyspent less time retreating to corners (p<0.0053), made more
contacts with the object (p<0.0449), and showed enhanced
horizontal (Fig. 6E, F) as well as vertical exploratory activity
toward the object (p<0.0409). By contrast, the behavior of
female KO mice in this test was indistinguishable from
controls, leading to genotype×gender interactions or trends in
all measures.
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Several S100 proteins have been located in the CNS [12], but
only S100B and S100A10 were studied for their involvement in
brain function using transgenic mouse models [31,32,48].
Considering the role of S100A1 in neuron morphogenesis and
growth, as well as in glia cell differentiation [14–17], S100A1
may be a prominent candidate protein regulating neural
functions. To provide insight into the in vivo role of S100A1
in the CNS, we established a line of S100A1-deficient mice by
gene trap mutagenesis. We confirmed the integration of the
retroviral vector in the S100A1 locus by PCR and Southern
hybridization, and conclude that the retroviral insertion was a
single event, leaving out the possibility that additional gene loci
have been affected. Since the gene trap insertion disrupted the
S100A1 protein midway, leaving exons 1/2 and exon 3 intact on
the 5′ and 3′ sides of the integration, respectively, we
considered the possibility of a hypomorphic S100A1 product
with putative dominant negative activity when fused to
β-galactosidase/neomycin phosphotransferase or puromycin
N-acetyltransferase. However, RT-PCR and immunoblot experi-
ments demonstrated that exon 2 of S100A1 is not part of the
marker/selector fusion transcript, whereas the β-galactosidase
gene is successfully put through RNA processing and
translation. This implies that β-galactosidase can be used as a
surrogate marker for the disrupted S100A1, and makes this
mouse line valuable for S100A1-promoter driven expression
analysis. In ES cells, the phosphoglycerate kinase-1 (PGK)
promoter produces a fusion transcript of puromycin N-
acetyltransferase and exon 3 of S100A1, based on which this
clone was selected for the generation of S100A1-disrupted
mice. Using RT-PCR, we showed that exon 3 expression was at
the detection limit in the KO, suggesting that the PGK promoter
is almost silent. This is consistent with previous findings,
reporting that heterologous promoters internal to a retrovirus are
inactive in differentiated cells [49,50] (and published Omnibank
gene-trapped mouse lines listed at http://www.lexgen.com). The
absence of S100A1 was additionally confirmed by northern
analysis and immunoblotting using a S100A1-specific probe
and antiserum, respectively.
S100A1-deficient mice were viable, fertile, grew normally
and did not exhibit striking phenotypic alterations throughout
their lifespan. Immunohistochemical staining of brain sections
from Wt mice demonstrated the presence of S100A1 protein in
the cerebral cortex, amygdala and stratum radiatum as well as
stratum pyramidale of the hippocampus, whereas staining was
completely absent in S100A1KO mice. S100A1-deficiency did
not result in abnormalities concerning brain size or morphology.
Using GFAP and NeuN as protein markers for astrocytes and
neurons, respectively, there were no apparent differences in the
distribution, shape and density of these cell types between Wt
and S100A1KO mice. Based on the intact cytoarchitecture of
S100A1KO brains, we cannot provide evidence that S100A1 is
an essential factor for nerve growth or glia cell differentiation.
S100A1 mRNA levels have been reported to be approximately
50% lower in S100BKO mice when compared to Wt of the
same strain [10]. We did not observe altered regulation ofS100B in glia cells of S100A1KO mice, suggesting that the
formation of S100A1/S100B dimers is not essential, and the
lack of S100A1 does not need to be compensated by higher
levels of S100B.
Water-maze data indicate that spatial learning and reference
memory is intact in KO mice. The slightly poorer annulus
crossing scores of female KO mice is probably due to their
increased wall hugging during the probe trial and mostly reflects
a more emotional reaction to the fact of not finding the goal in
the expected place. Clear selective searching was present in all
groups. Therefore, S100A1 is not essential for spatial memory.
Loss of S100A1 function is associated with reduced anxiety-
like responses and enhanced exploratory behavior. Effects in all
five tests point in the same direction: diminished anxiety-related
reactions and/or increased exploration of unknown territory or
objects. Changes are relatively modest in the open field and LD-
box. They are stronger and associated with a general increase of
activity on the O-maze and in the emergence/object exploration
test. Even though significant genotype×gender interactions are
not present in all measures, the data all together strongly suggest
that exploratory behavior is more strongly affected by the
mutation in male mice than in females. This could be due either
to gender-related differences of native S100A1 expression, or
some gender dependent compensation mechanism that fully or
partially masks the mutation effect in females but not in males.
Hitherto, the role of S100 proteins in learning, memory and
innate behavior has only been studied in a few animal models.
Administration of anti-S100A1 antibodies in chicks immediate-
ly after training for a passive avoidance task was demonstrated to
cause amnesia [19]. We did not find impaired spatial reference
memory in our mouse model of S100A1 deficiency. This does
not exclude that S100A1 plays a role in other forms of memory,
which are not hippocampus-dependent. Our results clearly show
that although members of the S100 protein family are similar in
structure and show overlapping expression patterns, they have
unique in vivo functions even within the CNS. S100BKO mice,
for instance, showed enhanced spatial memory in the water maze
as revealed by more crossings over the point where the platform
had been located [31]. In the case of S100A10, which
predominantly occurs in certain types of neurons, loss-of-
function in the mouse model revealed a depression-like
phenotype in the tail suspension test and increased anxiety-
related distress in the open field paradigm [48]. We have not
specifically tested S100A1KO mice for depression-like behav-
ior. Our tests on innate fear and exploratory behavior, however,
revealed reduced anxiety-like responses and enhanced explor-
atory behavior, both of which would not be characteristic for
mice with a potentially depression-like phenotype.
The present study demonstrates the occurrence of S100A1 in
the cerebral cortex, the amygdala, the stratum pyramidale and
stratum radiatum of the hippocampus. Based on co-localization
with GFAP in the stratum radiatum, we identified S100A1-
immunoreactive cells as astrocytes. In the brain regions, where
S100A1 did not co-localize with the astrocyte marker GFAP or
the neuronal marker NeuN, the identity of S100A1-positive
cells is still elusive. Behavioral analysis revealed that S100A1 is
involved in anxiety-like responses and exploratory behavior.
1318 G.E. Ackermann et al. / Biochimica et Biophysica Acta 1763 (2006) 1307–1319Differences to Wt mice were most prominent in KO males,
suggesting inherent sex differences based on the loss of S100A1
or modulation by gonadal hormones in coping with novel
situations. Alterations in catecholamine neurotransmitter con-
centrations would be a starting-point to explain some of the
behavioral changes, since norepinephrine and serotonin play
prominent roles in anxiety-like behavior [51,52] and dopami-
nergic signaling is involved in explorative reactions to novel
stimuli [42]. However, catecholamine neurotransmitter metab-
olite measurements in whole brain extracts revealed no dif-
ferences between Wt and KO mice. Differential analysis by
brain region, i.e. the amygdala, prefrontal context and striatum,
which are involved in anxiety-like responses and exploratory
behavior, would possibly reveal more specific alterations due to
S100A1-deficiency. The findings that S100A1 is expressed in
the amygdala and associated with altered anxiety-like
responses posit that S100A1 is involved in neural circuits for
innate fear. Likewise, immunolocalization of S100A1 in brain
regions associated with exploratory behavior would streng-
then a possible role of S100A1 in novelty-seeking. Using
S100A1KO mice as a resource, functional studies at the cellular
level would reveal more about the involvement of S100A1 in
avoidance-approach behavior.
Acknowledgements
This research was supported by the Swiss National Science
Foundation and the NCCR “Neural Plasticity and Repair”
(C.W.H. and D.P.W.), by the Research Grants Council of the
Hong Kong Special Administrative Region (Project no.
CUHK4421/05M) (W.Y.C. and C.W.H.) and by the SHK—
Stiftung für Herz- und Kreislaufkrankheiten (P.E.).
The authors thank the technicians for their excellent
technical help, i.e. C. Bosshart, C. Gemperle and L. Kierat for
genotyping, RT-PCR, immunoblotting and neurotransmitter
determination, L.Wang and T.F. Wan for immunohistochemis-
try, I. Drescher, R. Lang for running the behavioral experiments
and C. Marth for helping to prepare Figs. 4–6.
References
[1] I. Marenholz, R. Lovering, C.W. Heizmann, An update of the S100
nomenclature, Biochim. Biophys. Acta. Mol. Cell Res. 1763 (2006)
1282–1283.
[2] L. Santamaria-Kisiel, A.C. Rintala-Dempsey, G.S. Shaw, Calcium-
dependent and -independent interactions of the S100 protein family,
Biochem. J. 396 (2006) 201–214.
[3] N.T. Wright, K.M. Varney, K.C. Ellis, J. Markowitz, R.K. Gitti, D.B.
Zimmer, D.J. Weber, The three-dimensional solution structure of Ca(2+)-
bound S100A1 as determined by NMR spectroscopy, J. Mol. Biol. 353
(2005) 410–426.
[4] G. Fritz, C.W. Heizmann, in: A. Messerschmidt, W. Bode, M. Cygler
(Eds.), Handbook of Metalloproteins, John Wiley & Sons, Chichester,
2004, pp. 529–540.
[5] J.C. Deloulme, B.J. Gentil, J. Baudier, Monitoring of S100 homodimer-
ization and heterodimeric interactions by the yeast two-hybrid system,
Microsc. Res. Tech. 60 (2003) 560–568.
[6] I. Marenholz, C.W. Heizmann, G. Fritz, S100 proteins in mouse and man:
from evolution to function and pathology (including an update of the
nomenclature), Biochem. Biophys. Res. Commun. 322 (2004) 1111–1122.[7] C.W. Heizmann, B.W. Schäfer, G. Fritz, in: R.A. Bradshaw, E. Dennis
(Eds.), Handbook of Cell Signaling, Elsevier Science, USA, 2003,
pp. 87–93.
[8] D.B. Zimmer, P. Wright Sadosky, D.J. Weber, Molecular mechanisms of
S100-target protein interactions, Microsc. Res. Tech. 60 (2003) 552–559.
[9] R. Donato, Intracellular and extracellular roles of S100 proteins, Microsc.
Res. Tech. 60 (2003) 540–551.
[10] D.B. Zimmer, J. Chaplin, A. Baldwin, M. Rast, S100-mediated signal
transduction in the nervous system and neurological diseases, Cell. Mol.
Biol. (Noisy-le-grand) 51 (2005) 201–214.
[11] E. Sturchler, J.A. Cox, I. Durussel, M. Weibel, C.W. Heizmann, S100A16,
a novel calcium-binding protein of the EF-hand superfamily, J Biol Chem
(in press).
[12] W.Y. Chan, C.L. Xia, D.C. Dong, C.W. Heizmann, D.T. Yew, Differential
expression of S100 proteins in the developing human hippocampus and
temporal cortex, Microsc. Res. Tech. 60 (2003) 600–613.
[13] V. Vives, G. Alonso, A.C. Solal, D. Joubert, C. Legraverend, Visualization
of S100B-positive neurons and glia in the central nervous system of EGFP
transgenic mice, J. Comp. Neurol. 457 (2003) 404–419.
[14] F. Benfenati, R. Ferrari, F. Onofri, C. Arcuri, I. Giambanco, R. Donato,
S100A1 codistributes with synapsin I in discrete brain areas and inhibits
the F-actin-bundling activity of synapsin I, J. Neurochem. 89 (2004)
1260–1270.
[15] D.B. Zimmer, A. Landar, Analysis of S100A1 expression during skeletal
muscle and neuronal cell differentiation, J. Neurochem. 64 (1995)
2727–2736.
[16] D.B. Zimmer, L.J. Van Eldik, Analysis of the calcium-modulated proteins,
S100 and calmodulin, and their target proteins during C6 glioma cell
differentiation, J. Cell Biol. 108 (1989) 141–151.
[17] D.B. Zimmer, E.H. Cornwall, P.D. Reynolds, C.M. Donald, S100A1
regulates neurite organization, tubulin levels, and proliferation in PC12
cells, J. Biol. Chem. 273 (1998) 4705–4711.
[18] H.J. Huttunen, J. Kuja-Panula, G. Sorci, A.L. Agneletti, R. Donato, H.
Rauvala, Coregulation of neurite outgrowth and cell survival by
amphoterin and S100 proteins through receptor for advanced glycation
end products (RAGE) activation, J. Biol. Chem. 275 (2000) 40096–40105.
[19] B.S. O'Dowd, W.Q. Zhao, K.T. Ng, S.R. Robinson, Chicks injected with
antisera to either S-100 alpha or S-100 beta protein develop amnesia for a
passive avoidance task, Neurobiol. Learn Mem. 67 (1997) 197–206.
[20] R. Gerlach, G. Demel, H.G. Konig, U. Gross, J.H. Prehn, A. Raabe, V.
Seifert, D. Kogel, Active secretion of s100b from astrocytes during
metabolic stress, Neuroscience (2006) 1697–1701.
[21] F. Tramontina, A.C. Tramontina, D.F. Souza, M.C. Leite, C. Gottfried,
D.O. Souza, S.T. Wofchuk, C.A. Goncalves, Glutamate uptake is
stimulated by extracellular S100B in hippocampal astrocytes, Cell. Mol.
Neurobiol. 26 (2006) 81–86.
[22] D. Kogel, M. Peters, H.G. Konig, S.M. Hashemi, N.T. Bui, V. Arolt, M.
Rothermundt, J.H. Prehn, S100B potently activates p65/c-Rel transcrip-
tional complexes in hippocampal neurons: clinical implications for the
role of S100B in excitotoxic brain injury, Neuroscience 127 (2004)
913–920.
[23] S.W. Barger, L.J. Van Eldik, S100 beta stimulates calcium fluxes in glial
and neuronal cells, J. Biol. Chem. 267 (1992) 9689–9694.
[24] R.H. Selinfreund, S.W. Barger, W.J. Pledger, L.J. Van Eldik, Neurotrophic
protein S100 beta stimulates glial cell proliferation, Proc. Natl. Acad. Sci.
U. S. A. 88 (1991) 3554–3558.
[25] F. Winningham-Major, J.L. Staecker, S.W. Barger, S. Coats, L.J. Van
Eldik, Neurite extension and neuronal survival activities of recombinant
S100 beta proteins that differ in the content and position of cysteine
residues, J. Cell Biol. 109 (1989) 3063–3071.
[26] D. Kligman, D.R. Marshak, Purification and characterization of a neurite
extension factor from bovine brain, Proc. Natl. Acad. Sci. U. S. A. 82
(1985) 7136–7139.
[27] L.J. Van Eldik, M.S. Wainwright, The Janus face of glial-derived S100B:
beneficial and detrimental functions in the brain, Restor. Neurol. Neurosci.
21 (2003) 97–108.
[28] P.M. Whitaker-Azmitia, Serotonin and brain development: role in human
developmental diseases, Brain Res. Bull. 56 (2001) 479–485.
1319G.E. Ackermann et al. / Biochimica et Biophysica Acta 1763 (2006) 1307–1319[29] H. Nishiyama, M. Takemura, T. Takeda, S. Itohara, Normal development
of serotonergic neurons in mice lacking S100B, Neurosci. Lett. 321 (2002)
49–52.
[30] R.H. Dyck, A. Bogoch II, N.R. Marks, G.C. Melvin, Enhanced
epileptogenesis in S100B knockout mice, Brain Res. Mol. Brain Res.
106 (2002) 22–29.
[31] H. Nishiyama, T. Knopfel, S. Endo, S. Itohara, Glial protein S100B
modulates long-term neuronal synaptic plasticity, Proc. Natl. Acad. Sci.
U. S. A. 99 (2002) 4037–4042.
[32] Z. Xiong, D. O'Hanlon, L.E. Becker, J. Roder, J.F. MacDonald, A. Marks,
Enhanced calcium transients in glial cells in neonatal cerebellar cultures
derived from S100B null mice, Exp. Cell Res. 257 (2000) 281–289.
[33] M.S. Chang, L.M. Ariah, A. Marks, E.C. Azmitia, Chronic gliosis induced
by loss of S-100B: knockout mice have enhanced GFAP-immunoreactivity
but blunted response to a serotonin challenge, Brain Res. 1031 (2005) 1–9.
[34] X.J. Du, T.J. Cole, N. Tenis, X.M. Gao, F. Kontgen, B.E. Kemp, J.
Heierhorst, Impaired cardiac contractility response to hemodynamic stress
in S100A1-deficient mice, Mol. Cell. Biol. 22 (2002) 2821–2829.
[35] B.P. Zambrowicz, G.A. Friedrich, E.C. Buxton, S.L. Lilleberg, C. Person,
A.T. Sands, Disruption and sequence identification of 2000 genes in mouse
embryonic stem cells, Nature 392 (1998) 608–611.
[36] S.M. Hossain, B.K. Wong, E.M. Simpson, The dark phase improves
genetic discrimination for some high throughput mouse behavioral
phenotyping, Genes Brain Behav. 3 (2004) 167–177.
[37] D.P. Wolfer, R. Madani, P. Valenti, H.P. Lipp, Extended analysis of path
data from mutant mice using the public domain software Wintrack,
Physiol. Behav. 73 (2001) 745–753.
[38] M.H. Mohajeri, R. Madani, K. Saini, H.P. Lipp, R.M. Nitsch, D.P. Wolfer,
The impact of genetic background on neurodegeneration and behavior in
seizured mice, Genes Brain Behav. 3 (2004) 228–239.
[39] R. Madani, S. Kozlov, A. Akhmedov, P. Cinelli, J. Kinter, H.P. Lipp, P.
Sonderegger, D.P. Wolfer, Impaired explorative behavior and neophobia in
genetically modified mice lacking or overexpressing the extracellular
serine protease inhibitor neuroserpin, Mol. Cell. Neurosci. 23 (2003)
473–494.
[40] J. Crawley, F.K. Goodwin, Preliminary report of a simple animal behavior
model for the anxiolytic effects of benzodiazepines, Pharmacol. Biochem.
Behav. 13 (1980) 167–170.[41] M. Konig, A.M. Zimmer, H. Steiner, P.V. Holmes, J.N. Crawley, M.J.
Brownstein, A. Zimmer, Pain responses, anxiety and aggression in mice
deficient in pre-proenkephalin, Nature 383 (1996) 535–538.
[42] S.C. Dulawa, D.K. Grandy, M.J. Low, M.P. Paulus, M.A. Geyer,
Dopamine D4 receptor-knock-out mice exhibit reduced exploration of
novel stimuli, J. Neurosci. 19 (1999) 9550–9556.
[43] D. Drai, I. Golani, SEE: a tool for the visualization and analysis of rodent
exploratory behavior, Neurosci. Biobehav. Rev. 25 (2001) 409–426.
[44] G. Keren, C. Lewis, Partial omega squared for ANOVA designs, Educ.
Psychol. Meas. 39 (1979) 119–128.
[45] W.L. Stanford, J.B. Cohn, S.P. Cordes, Gene-trap mutagenesis: past,
present and beyond, Nat. Rev., Genet. 2 (2001) 756–768.
[46] M. Gallagher, R. Burwell, M. Burchinal, Severity of spatial learning
impairment in aging: development of a learning index for performance in
the Morris water maze, Behav. Neurosci. 107 (1993) 618–626.
[47] I.Q. Whishaw, Cholinergic receptor blockade in the rat impairs locale but
not taxon strategies for place navigation in a swimming pool, Behav.
Neurosci. 99 (1985) 979–1005.
[48] P. Svenningsson, K. Chergui, I. Rachleff, M. Flajolet, X. Zhang, M. El
Yacoubi, J.M. Vaugeois, G.G. Nomikos, P. Greengard, Alterations in 5-
HT1B receptor function by p11 in depression-like states, Science 311
(2006) 77–80.
[49] S. Kuriyama, T. Sakamoto, M. Kikukawa, T. Nakatani, Y. Toyokawa,
H. Tsujinoue, K. Ikenaka, H. Fukui, T. Tsujii, Expression of a
retrovirally transduced gene under control of an internal housekeep-
ing gene promoter does not persist due to methylation and is
restored partially by 5-azacytidine treatment, Gene Ther. 5 (1998)
1299–1305.
[50] C.L. Stewart, S. Schuetze, M. Vanek, E.F. Wagner, Expression of retroviral
vectors in transgenic mice obtained by embryo infection, EMBO J. 6
(1987) 383–388.
[51] M.D. Marino, B.N. Bourdelat-Parks, L. Cameron Liles, D. Weinshenker,
Genetic reduction of noradrenergic function alters social memory and
reduces aggression in mice, Behav. Brain Res. 161 (2005) 197–203.
[52] L.K. Heisler, H.M. Chu, T.J. Brennan, J.A. Danao, P. Bajwa, L.H. Parsons,
L.H. Tecott, Elevated anxiety and antidepressant-like responses in
serotonin 5-HT1A receptor mutant mice, Proc. Natl. Acad. Sci. U. S. A.
95 (1998) 15049–15054.
